Cancer Gene Therapy Market Size, Share, Opportunities, COVID 19 Impact, And Trends By Type (Gene Transfer, Genetically Engineered Viruses, Immunotherapy, Others), By End User (Hospitals, Clinical Research Organisations, Biotech Companies, Research Institutes), And By Geography - Forecasts From 2019 To 2024

Published:  May 2020 Report Code: KSI061612055 Pages: 96

The global cancer gene therapy market is expected to grow at a CAGR of 16.92% reach US$4.111 billion by 2024 from US$1.454 billion in 2018. Gene therapy is an experimental technique that involves the introduction of DNA usually containing a functional gene t into a patient for the treatment of genetic disorders. Gene therapy works by replacing, repairing, or repressing the mutated gene. Gene therapy is being studied in the treatment of certain types of cancer (source: National Cancer Institute, National Institutes of Health).

The growing incidence and prevalence of cancer worldwide are emanating the demand for cancer gene therapy fuelling the market growth. Research and Innovations in the treatment of cancer are also driving the growth of the global cancer gene therapy market in the forecast period. An analysis of health claims data from two demographically similar regions on either side of the U.S. and Canada border shows that a common treatment for advanced colorectal cancer costs twice as much in Western Washington State (WW) than in British Columbia (BC) -- $12,345 vs. $6,195 monthly per patient. Despite the higher cost, the patients on the U.S. side of the border are not living longer than those on the Canadian side (source: American Society of Clinical Oncology, ASCO). Thus, the high cost of cancer treatment is a major factor restraining the market growth in the forecast period.

The Global Cancer Gene Therapy Market – Forecasts from 2019 to 2024” is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key markets, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by Type, End-User, and geography.

Based on type, the market has been segmented as Gene Transfer, Genetically Engineered Viruses, Immunotherapy, and Others. On the basis of End-users, the global cancer gene therapy market is segmented as Hospitals, Clinical Research Organisations, Biotech Companies, and Research Institutes.

Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, the Middle East and Africa, and Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the Cancer Gene Therapy market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the Cancer Gene Therapy market.

Cancer Gene Therapy Market Scope:

Report Metric Details
 Market size value in 2018  US$1.454 billion
 Market size value in 2024  US$4.111 billion
 Growth Rate  CAGR of 16.92% from 2018 to 2024
 Base year  2018
 Forecast period  2019–2024
 Forecast Unit (Value)  USD Billion
 Segments covered  Type, End-users, And Geography
 Regions covered  North America, South America, Europe, Middle East and Africa, Asia Pacific
 Companies covered  Shenzhen Sibiono Genetech, Sunway Biotech Co. Ltd., Amgen, Novartis, Gilead   Sciences
 Customization scope  Free report customization with purchase

 

Segmentation:

  • By Type
    • Gene Transfer
    • Genetically Engineered Viruses
    • Immunotherapy
    • Others
  • By End-users
    • Hospitals
    • Clinical Research Organisations
    • Biotech Companies
    • Research Institutes
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • Italy
      • Spain
      • Others
    • Middle East and Africa (MEA)
      • Israel
      • Saudi Arabia
      • Others
    • Asia Pacific (APAC)
      • China
      • Japan
      • India
      • Australia
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the cancer gene therapy market size by 2024?
A1. The global cancer gene therapy market is expected to reach a total market size of US$4.111 billion in 2024.

Q2. What are the growth prospects for cancer gene therapy market?
A2. The cancer gene therapy market is expected to grow at a CAGR of 16.92% over the forecast period.

Q3. What is the size of global cancer gene therapy market?
A3. Cancer Gene Therapy market was valued at US$1.454 billion in 2018.

Q4. What factors are anticipated to drive the cancer gene therapy market growth?
A4. The growing incidence and prevalence of cancer worldwide are emanating the demand for cancer gene therapy fuelling market growth.

Q5. How is the global cancer gene therapy market segmented?
A5. The global cancer gene therapy market has been segmented by type, end-user, and geography.

1. Introduction

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the study

1.4. Currency

1.5. Assumptions

1.6. Base, and Forecast Years Timeline

2. Research methodology

2.1. Research Design

2.2. Secondary Sources

3. Executive Summary

4. Market Dynamics

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter’s Five Forces Analysis

4.5.1. Bargaining Power of Suppliers

4.5.2. Bargaining Power of Buyers

4.5.3. Threat of New Entrants

4.5.4. Threat of Substitutes

4.5.5. Competitive Rivalry in the Industry

4.6. Life Cycle Analysis - Regional Snapshot

4.7. Market Attractiveness

5. Cancer Gene Therapy Market by Type

5.1. Gene Transfer

5.2. Genetically Engineered Viruses

5.3. Immunotherapy

5.4. Others

6. Cancer Gene Therapy Market by End-User

6.1. Hospitals

6.2. Clinical Research Organisations

6.3. Biotech Companies

6.4. Research Institutes

7. Cancer Gene Therapy Market by Geography

7.1. North America

7.1.1. North America Cancer Gene Therapy Market, By Type, 2018 to 2024

7.1.2. North America Cancer Gene Therapy Market, By End-User, 2018 to 2024

7.1.3. By Country

7.1.3.1. USA

7.1.3.2. Canada

7.1.3.3. Mexico

7.2. South America

7.2.1. South America Cancer Gene Therapy Market, By Type, 2018 to 2024

7.2.2. South America Cancer Gene Therapy Market, By End-User, 2018 to 2024

7.2.3. By Country

7.2.3.1. Brazil

7.2.3.2. Argentina

7.2.3.3. Others

7.3. Europe

7.3.1. Europe Cancer Gene Therapy Market, By Type, 2018 to 2024

7.3.2. Europe Cancer Gene Therapy Market, By End-User, 2018 to 2024

7.3.3. By Country

7.3.3.1. UK

7.3.3.2. Germany

7.3.3.3. Italy

7.3.3.4. Spain

7.3.3.5. Others

7.4. Middle East and Africa

7.4.1. Middle East and Africa Cancer Gene Therapy Market, By Type, 2018 to 2024

7.4.2. Middle East and Africa Cancer Gene Therapy Market, By End-User, 2018 to 2024

7.4.3. By Country

7.4.3.1. Israel

7.4.3.2. Saudi Arabia

7.4.3.3. Others

7.5. Asia Pacific

7.5.1. Asia Pacific Cancer Gene Therapy Market, By Type, 2018 to 2024

7.5.2. Asia Pacific Cancer Gene Therapy Market, By End-User, 2018 to 2024

7.5.3. By Country

7.5.3.1. China

7.5.3.2. Japan

7.5.3.3. India

7.5.3.4. Australia

7.5.3.5. Others

8. Competitive intelligence

8.1. Competitive Benchmarking and Analysis

8.2. Strategies of Key Players

8.3. Recent Investments and Deals

9. Company Profile

9.1. Shenzhen Sibiono Genetech

9.2. Sunway Biotech Co. Ltd.

9.3. Amgen

9.4. Novartis

9.5. Gilead Sciences

List is not Exhaustive

Shenzhen Sibiono Genetech

Sunway Biotech Co. Ltd.

Amgen

Novartis

Gilead Sciences

List is not Exhaustive*

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us